The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mcneill Jonathan since 2021.
This trader's CIK number is 1824673.
At the time of last reporting, Mcneill Jonathan was the Chief Business Officer of Dyne Therapeutics, Inc.. (stock ticker symbol DYN).
Also see all insider trading activities at Dyne Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | DYN | 0 | $0 | 199,765 | $5,054,199 | 176,353 | $647,373 |
| 2023 | DYN | 0 | $0 | 18,240 | $236,455 | 10,000 | $7,300 |
| 2022 | DYN | 0 | $0 | 481 | $4,199 | 0 | $0 |
| 2021 | DYN | 0 | $0 | 1,274 | $20,251 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-19 | DYN | Sale | 2,705 | 45.51 | 123,091 |
| 2024-06-11 | DYN | Sale | 1,823 | 31.34 | 57,132 |
| 2024-05-16 | DYN | Sale | 2,774 | 28.39 | 78,767 |
| 2024-03-08 | DYN | Sale | 90,000 | 26.50 | 2,384,730 |
| 2024-03-11 | DYN | Option Ex | 17,825 | 5.54 | 98,750 |
| 2024-03-11 | DYN | Sale | 19,601 | 25.59 | 501,687 |
| 2024-03-08 | DYN | Option Ex | 90,000 | 5.54 | 498,600 |
| 2024-03-07 | DYN | Sale | 2,434 | 25.85 | 62,918 |
| 2024-03-01 | DYN | Option Ex | 24,260 | .73 | 17,709 |
| 2024-02-29 | DYN | Option Ex | 4,268 | .73 | 3,115 |
| 2024-03-01 | DYN | Sale | 24,260 | 29.00 | 703,612 |
| 2024-02-29 | DYN | Sale | 4,268 | 27.50 | 117,370 |
| 2024-01-26 | DYN | Option Ex | 20,000 | .73 | 14,600 |
| 2024-01-26 | DYN | Sale | 20,000 | 24.83 | 496,599 |
| 2024-01-03 | DYN | Sale | 17,991 | 18.68 | 336,161 |
| 2024-01-04 | DYN | Sale | 2,009 | 18.04 | 36,242 |
| 2024-01-03 | DYN | Option Ex | 17,991 | .73 | 13,133 |
| 2024-01-02 | DYN | Sale | 11,900 | 13.10 | 155,890 |
| 2024-01-04 | DYN | Option Ex | 2,009 | .73 | 1,466 |
| 2023-12-11 | DYN | Sale | 1,245 | 10.72 | 13,346 |
| 2023-09-18 | DYN | Sale | 1,261 | 9.41 | 11,866 |
| 2023-09-12 | DYN | Sale | 1,266 | 10.41 | 13,179 |
| 2023-06-13 | DYN | Sale | 1,259 | 12.43 | 15,649 |
| 2023-06-12 | DYN | Sale | 1,000 | 13.00 | 13,000 |
| 2023-03-13 | DYN | Sale | 1,000 | 13.00 | 13,000 |
| 2023-03-14 | DYN | Sale | 1,209 | 13.33 | 16,115 |
| 2023-01-18 | DYN | Option Ex | 10,000 | .73 | 7,300 |
| 2023-01-18 | DYN | Sale | 10,000 | 14.03 | 140,300 |
| 2022-03-11 | DYN | Sale | 481 | 8.73 | 4,199 |
| 2021-09-20 | DYN | Sale | 545 | 15.61 | 8,507 |
| 2021-09-21 | DYN | Sale | 729 | 16.11 | 11,744 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcneill Jonathan (Chief Business Officer of Dyne Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.